- Active not recruitingPHASE2, PHASE3
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy
This study looks at new drug combinations for advanced non-small cell lung cancer that has progressed after standard treatments. It compares adding new medicines, cobolimab and dostarlimab, to docetaxel chemotherapy, to see if they work better together.
For: Lung Cancer, Non-Small CellUnited States · Argentina · Australia - Active not recruitingPHASE1
Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors
This study is testing new medicines for advanced cancers that have grown. It particularly looks at how safe these new drugs are and how well they work, both alone and with existing treatments. The research also wants to understand how the body uses these new drugs.
For: NeoplasmsUnited States · Canada · Japan